This activity is provided by Med Learning Group.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Copyright © 2019Med Learning Group. Built by Divigner. All Rights Reserved.
Increasing diversity within ophthalmic clinical trials, including within the retina subspecialty, has various underlying factors that need to be addressed to foster trust, enhance awareness, and facilitate participation. Efforts on the individual and collective level can do several things to improve diversity within clinical trials.
On the collective level, the American Academy of Ophthalmology (AAO) has established a task force focused on health equity in eye care. This task force takes a closer look at topics such as the social determinants of health and medical care, access to care, and care outcomes. The AAO is also committed to developing meaningful patient and provider resources to help address this need for greater diversity, equity, and inclusion.10
Additionally, both pharmaceutical companies and the FDA are making efforts to focus on inclusion within clinical trials for all specialties. In its November 2020 “Enhancing the Diversity of Clinical Trial Populations” document, the FDA suggested several ways that clinical trials can increase diversity and inclusion.11 Some of its recommendations include:
Additionally, both pharmaceutical companies and the FDA are making efforts to focus on inclusion within clinical trials for all specialties. In its November 2020 “Enhancing the Diversity of Clinical Trial Populations” document, the FDA suggested several ways that clinical trials can increase diversity and inclusion.11 Some of its recommendations include:
Although studies have shown some narrowing of disparities in ophthalmic trial underrepresentation from 2000 to 2020, continued efforts for engagement with underrepresented groups to diversify trial composition are vital to ensure the quality and validity of trial results.5
This activity is provided by Med Learning Group.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Copyright © 2019Med Learning Group. Built by Divigner. All Rights Reserved.